Judge won’t block Lilly ads for weight-loss drugs in ruling against Novo Nordisk
The dispute involves advertisements by Lilly for Zepbound and Mounjaro that claim the drugs are superior to Novo’s Wegovy and Ozempic.
Pharmaceuticals
Articles
Lilly fighting black market for its next obesity drug
On Aug. 12, Eli Lilly filed the first six lawsuits in its battle against the black market for its experimental weight-loss medication retatrutide.
Pharmacist accused of lengthy drug diversion gives up bid to renew Indiana license
The withdrawal means Christopher Knoth’s Indiana pharmacist license will remain expired and he cannot legally practice. He faces several felony charges.
Indiana Public Retirement System secures $69M settlement with pharma company
The company was accused of making false statements regarding the safety of one of its drugs, leading investors to purchase stocks they otherwise would not have.
Pharmacy board narrowly accepts drug diversion settlement with IU Health’s Muncie hospital
Indiana’s pharmacy regulators reluctantly approved the disciplinary settlement over what they describe as one of the largest known drug theft cases in state history.
7th Circuit restores breach-of-contract case against Eli Lilly
The appellate court held that Teva plausibly alleged that Lilly breached the two companies’ 2018 settlement agreement, which stipulated that Lilly would not interfere with Teva getting approval for a generic version of Lilly’s osteoporosis drug, Forteo.
Supreme Court rejects appeals from drug manufacturers over Medicare price negotiations
The negotiation program was created as part of the 2022 Inflation Reduction Act, which capped years of debate over whether the federal government should be allowed to haggle directly with pharmaceutical companies over the prices of drugs in Medicare.
Lilly rebuffed by Supreme Court on $194M Medicaid award
The case against Lilly centered on the rebates that drug companies must pay to state Medicaid programs to subsidize some of the cost.
‘Not enough’: Indiana pharmacy board rejects hospital deal in drug diversion case
Regulators said $44K in penalties tied to former pharmacist’s alleged drug theft falls short in what’s been flagged as one of Indiana’s largest-ever diversions.
Indiana attorney general sues Lilly over insulin prices
Attorney General Todd Rokita said the lawsuit, filed last Wednesday in the Lake County Superior Court, is part of his office’s intensifying efforts to lower insulin prices and improve health care affordability.
Judge formally approves Purdue Pharma opioid settlement, with Sacklers paying up to $7B
Thousands of victims of the opioid epidemic could be paid thousands of dollars each, with a portion of the money distributed next year to some people who had OxyContin prescriptions and their survivors.
Pharmacists press lawmakers to drop ‘out of date’ law test from licensing requirements
An often-outdated pharmacy law test is “absolutely” making Indiana lose would-be pharmacists — and it shouldn’t be a licensing requirement, medical professionals told lawmakers Thursday.
Brandon Shirley, Madison Hartman Harada & Thomas Abrams: Indiana limits pharmacy benefit manager vertical integration
The new law introduces multiple changes to how pharmacy benefits are managed and delivered in Indiana.
Trump signs executive order setting 30-day deadline for drugmakers to lower prescription drug costs
The order calls on the health department to broker new price tags for drugs. If a deal is not reached, a new rule will kick in that will tie the price of what the U.S. pays for medications to lower prices paid by other countries.
Roche Diagnostics to invest up to $550M in Indianapolis, adding hundreds of local jobs
Roche said Monday’s news was “aligning with national efforts to strengthen local manufacturing.”
Purdue Pharma and owners to pay $7.4B in settlement over OxyContin’s toll
The deal represents an increase of more than $1 billion over a previous settlement deal that was rejected last year by the U.S. Supreme Court.
Indiana attorney general sues drug companies over EpiPen prices
The 107-page lawsuit claims Mylan and Pfizer conspired to increase EpiPen’s price by more than 600% and prevented similar products from coming to market. Pfizer denied the allegations. Mylan did not immediately respond to a request for comment.
Walgreens to pay $106M to settle allegations it submitted false payment claims for prescriptions
Walgreens has agreed to pay $106 million to settle lawsuits that alleged the pharmacy chain submitted false payment claims with government health care programs for prescriptions that were never dispensed.
The Supreme Court rejects a nationwide opioid settlement with OxyContin maker Purdue Pharma
The Supreme Court on Thursday rejected a nationwide settlement with OxyContin maker Purdue Pharma that would have shielded members of the Sackler family who own the company from civil lawsuits over the toll of opioids but also would have provided billions of dollars to combat the opioid epidemic.
OxyContin marketer agrees to pay $350M rather than face lawsuits
An advertising agency that helped develop marketing campaigns for OxyContin and other prescription painkillers has agreed to pay U.S. states $350 million rather than face the possibility of trials over its role in the opioid crisis.